Search Results - "Sodani, Kamlesh"
-
1
Revisiting the ABCs of multidrug resistance in cancer chemotherapy
Published in Current pharmaceutical biotechnology (01-04-2011)“…The adenosine tri-phosphate binding cassette (ABC) transporters are one of the largest transmembrane gene families in humans. The ABC transporters are present…”
Get more information
Journal Article -
2
Nilotinib potentiates anticancer drug sensitivity in murine ABCB1-, ABCG2-, and ABCC10-multidrug resistance xenograft models
Published in Cancer letters (28-01-2013)“…Highlights ► Nilotinib compared to panel of tyrosine kinase inhibitors most potently reverse ABCB1, ABCG2 and ABCC10 transporters mediated drug resistance. ►…”
Get full text
Journal Article -
3
GW583340 and GW2974, human EGFR and HER-2 inhibitors, reverse ABCG2- and ABCB1-mediated drug resistance
Published in Biochemical pharmacology (15-06-2012)“…The overexpression of ATP binding cassette (ABC) transporters often leads to the development of multidrug resistance (MDR) and results in a suboptimal response…”
Get full text
Journal Article -
4
Reversal of MRP7 (ABCC10)-mediated multidrug resistance by tariquidar
Published in PloS one (05-02-2013)“…Multidrug resistance protein 7 (MRP7, ABCC10) is a recently discovered member of the ATP-binding cassette (ABC) family which are capable of conferring…”
Get full text
Journal Article -
5
PDE5 inhibitors, sildenafil and vardenafil, reverse multidrug resistance by inhibiting the efflux function of multidrug resistance protein 7 (ATP‐binding Cassette C10) transporter
Published in Cancer science (01-08-2012)“…Phosphodiesterase type 5 (PDE5) inhibitors are widely used in the treatment of male erectile dysfunction and pulmonary hypertension. Recently, several groups…”
Get full text
Journal Article -
6
WHI‐P154 enhances the chemotherapeutic effect of anticancer agents in ABCG2‐overexpressing cells
Published in Cancer science (01-08-2014)“…ATP‐binding cassette (ABC) transmembrane proteins evidently decrease the intracellular accumulation of substrate chemotherapeutic drugs by extruding them…”
Get full text
Journal Article -
7
Sulindac sulfide selectively increases sensitivity of ABCC1 expressing tumor cells to doxorubicin and glutathione depletion
Published in Journal of biomedical research (01-01-2016)“…ATP-binding cassette(ABC) transporters ABCC1(MRP1),ABCB1(P-gp),and ABCG2(BCRP) contribute to chemotherapy failure.The primary goals of this study were to…”
Get full text
Journal Article -
8
bba, a synthetic derivative of 23-hydroxybutulinic acid, reverses multidrug resistance by inhibiting the efflux activity of MRP7 (ABCC10)
Published in PloS one (17-09-2013)“…Natural products are frequently used for adjuvant chemotherapy in cancer treatment. 23-O-(1,4'-bipiperidine-1-carbonyl) betulinic acid (BBA) is a synthetic…”
Get full text
Journal Article -
9
Multidrug resistance associated proteins in multidrug resistance
Published in Ai zheng (01-02-2012)“…Multidrug resistance proteins (MRPs) are members of the C family of a group of proteins named ATP- binding cassette (ABC) transporters. These ABC transporters…”
Get full text
Journal Article -
10
PD173074, a selective FGFR inhibitor, reverses MRP7 (ABCC10)-mediated MDR
Published in Acta pharmaceutica Sinica. B (01-06-2014)“…Multidrug resistance protein 7 (MRP7, ABCC10) is a recently identified member of the ATP-binding cassette (ABC) transporter family, which adequately confers…”
Get full text
Journal Article -
11
Nilotinib (AMN107, Tasigna ®) reverses multidrug resistance by inhibiting the activity of the ABCB1/Pgp and ABCG2/BCRP/MXR transporters
Published in Biochemical pharmacology (15-07-2009)“…Nilotinib, a BCR-Abl tyrosine kinase inhibitor (TKI), was developed to surmount resistance or intolerance to imatinib in patients with Philadelphia positive…”
Get full text
Journal Article -
12
Correction to “BBA, a Derivative of 23-Hydroxybetulinic Acid, Potently Reverses ABCB1-Mediated Drug Resistance in Vitro and in Vivo”
Published in Molecular pharmaceutics (05-06-2023)Get full text
Journal Article -
13
Telatinib reverses chemotherapeutic multidrug resistance mediated by ABCG2 efflux transporter in vitro and in vivo
Published in Biochemical pharmacology (01-05-2014)“…[Display omitted] Multidrug resistance (MDR) is a phenomenon where cancer cells become simultaneously resistant to anticancer drugs with different structures…”
Get full text
Journal Article -
14
Suppression of ABCG2 mediated MDR in vitro and in vivo by a novel inhibitor of ABCG2 drug transport
Published in Pharmacological research (01-07-2017)“…[Display omitted] Cancer is a disease whose treatment is often limited due to the development of a phenomenon known as multidrug resistance (MDR). There is an…”
Get full text
Journal Article -
15
PD173074, a selective FGFR inhibitor, reverses ABCB1-mediated drug resistance in cancer cells
Published in Cancer chemotherapy and pharmacology (01-07-2013)“…Purpose Specific tyrosine kinase inhibitors were recently reported to modulate the activity of ABC transporters, leading to an increase in the intracellular…”
Get full text
Journal Article -
16
Lapatinib and erlotinib are potent reversal agents for MRP7 (ABCC10)-mediated multidrug resistance
Published in Biochemical pharmacology (15-01-2010)“…In recent years, a number of TKIs (tyrosine kinase inhibitors) targeting epidermal growth factor receptor (EGFR) family have been synthesized and some have…”
Get full text
Journal Article -
17
Masitinib antagonizes ATP-binding cassette subfamily C member 10-mediated paclitaxel resistance: a preclinical study
Published in Molecular cancer therapeutics (01-03-2014)“…Paclitaxel displays clinical activity against a wide variety of solid tumors. However, resistance to paclitaxel significantly attenuates the response to…”
Get full text
Journal Article -
18
β-elemene, a compound derived from Rhizoma zedoariae, reverses multidrug resistance mediated by the ABCB1 transporter
Published in Oncology reports (01-02-2014)“…In the present in vitro study, we examined the effect of the compound β-elemene on the response of KB-C2 cells overexpressing the ABCB1 transporter to specific…”
Get full text
Journal Article -
19
Saracatinib (AZD0530) is a potent modulator of ABCB1‐mediated multidrug resistance in vitro and in vivo
Published in International journal of cancer (01-01-2013)“…Saracatinib, a highly selective, dual Src/Abl kinase inhibitor, is currently in a Phase II clinical trial for the treatment of ovarian cancer. In our study, we…”
Get full text
Journal Article -
20
BBA, a Derivative of 23-Hydroxybetulinic Acid, Potently Reverses ABCB1-Mediated Drug Resistance in Vitro and in Vivo
Published in Molecular pharmaceutics (05-11-2012)“…23-O-(1,4′-Bipiperidine-1-carbonyl)betulinic acid (BBA), a synthetic derivative of 23-hydroxybetulinic acid (23-HBA), shows a reversal effect on multidrug…”
Get full text
Journal Article